Kidney injury molecule‐1 and N‐acetyl‐ß‐d‐glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome
- 1 October 2011
- journal article
- research article
- Published by Wiley in European Journal of Heart Failure
- Vol. 13 (10), 1104-1110
- https://doi.org/10.1093/eurjhf/hfr102
Abstract
Patients with chronic heart failure are often characterized by impaired renal function, also referred to as cardiorenal syndrome (CRS). The aim of this study was to assess whether novel markers of kidney injury are elevated in chronic heart failure and CRS. The new renal biomarkers kidney injury molecule-1 (KIM-1), N-acetyl-ß-d-glucosaminidase (NAG) and neutrophil gelatinase-associated lipocalin (NGAL) were assessed from urine samples of 173 individuals. Patients with chronic heart failure (n= 150) were characterized by decreased ejection fraction (32 ± 9% vs. controls 62 ± 4%, P < 0.001) and increased plasma N-terminal pro-brain natriuretic peptide (median 1460 pg/mL, interquartile range (IQR) 630-3000 pg/mL vs. controls 56, IQR 25-64l pg/mL, P < 0.001). Urinary analysis showed that KIM-1 was significantly elevated in heart failure patients compared with healthy controls (1100, IQR 620-1920 vs. 550, IQR 320-740 ng/g urinary creatinine, P < 0.001). Further, KIM-1 increased significantly with decreasing left ventricular function (r = -0.37, P < 0.001) and severity of New York Heart Association (NYHA)-class (r = 0.5, P < 0.001). N-acetyl-ß-d-glucosaminidase showed a weaker response but correlated significantly with left ventricular dysfunction (r = -0.18, P= 0.015) and more severe clinical condition (r = 0.22, P= 0.04). In contrast, NGAL showed no significant correlation. Kidney injury molecule-1 and NAG were also predictors of all-cause mortality and the composite of all-cause mortality and rehospitalization for heart failure (all P < 0.05). Kidney injury molecule-1 and NAG are elevated in symptomatic heart failure. This finding may be present in patients with apparently normal kidney function and indicates tubular injury in chronic heart failure. Kidney injury molecule-1 and NAG are potential markers of CRS with additional prognostic value.This publication has 23 references indexed in Scilit:
- The cardiorenal anaemia syndrome in systolic heart failure: prevalence, clinical correlates, and long‐term survivalEuropean Journal of Heart Failure, 2011
- The impact of impaired renal function on mortality in patients with acutely decompensated chronic heart failureEuropean Journal of Heart Failure, 2010
- Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality InitiativeEuropean Heart Journal, 2009
- Acute kidney injury and outcomes in acute decompensated heart failure: evaluation of the RIFLE criteria in an acutely ill heart failure populationEuropean Journal of Heart Failure, 2009
- Both in‐ and out‐hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH)European Journal of Heart Failure, 2009
- Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgeryThe Lancet, 2005
- The severe cardiorenal syndrome: ‘Guyton revisited’European Heart Journal, 2004
- The Clinical Challenge of Cardiorenal SyndromeCirculation, 2004
- Activity and isoenzyme profile of N-acetyl-β-d-glucosaminidase in urine from workers exposed to cadmiumClinica Chimica Acta; International Journal of Clinical Chemistry, 2000
- Kidney Injury Molecule-1 (KIM-1), a Putative Epithelial Cell Adhesion Molecule Containing a Novel Immunoglobulin Domain, Is Up-regulated in Renal Cells after InjuryOnline Journal of Public Health Informatics, 1998